About MAQC

The objective of the MAQC Society is to communicate, promote, and advance reproducible science principles and quality control for analysis of the massive data generated from the existing and emerging technologies in solving biological, health, and medical problems. Thus, the goals of the Society are to (1) advocate and facilitate the development and application of quality control practice and standard analysis protocols of bioinformatics and biostatistics for enhanced reproducibility across multiple experiments, laboratories, and data analysis methods, and (2) advance our understanding and best practices in the analysis of massive data from emerging technologies applied in drug development, clinical application, and safety/risk assessment.

MAQC SOCIETY AT A GLANCE

A Bit of Background

Historically, the MAQC/SEQC has been a US FDA‐led community-wide consortium effort to address issues relating to the application of constantly evolving high‐throughput genomics technologies to either assess safety and efficacy of FDA regulated products or their safe and effective use in clinical applications as in vitro diagnostic devices. The MAQC consortium completed three projects between 2005 ‐2014 (namely MAQC I, II and III/SEQC), resulting in ~30 publications, one third of which were published in Nature Biotechnology. Furthermore, two of these papers were among the most cited in Nature Biotechnology in the last 20 years. The MAQC Society is currently completing work on SEQC2 resulting in additional publications in Nature Biotechnology and other journals regarding best practices in DNA analysis. Additional information about MAQC Consortium projects is available here. The success enjoyed by consortium members led us to create a new society whose mission is to promote reproducible scientific research, especially research that involves analysis of massive data sets but which include additional areas benefiting human health: medical and pathology imaging, proteomics and other -omics, large health-related studies and databases, etc.

MAQC Society Board of Directors

A Board of Directors is chartered to develop the Society and oversee the Society’s activities. Specifically, the Board is dedicated to building and strengthening the reproducible science practice by (1) engaging scientists in academia, industry, and government, (2) fostering collaboration and harmonization of education, research tools, and new technologies, and (3) building the global-scientific infrastructure needed to advance and promote reproducible science.
weida_sq

Dr. Weida Tong

Chairperson of the Board - MAQC Society

Director
MCBIOS President
Division of Bioinformatics and Biostatistics National Center for Toxicological Research
Food and Drug Administration (FDA)

steve_sq

Dr. Wendell Jones

President

Principal Bioinformaticist and Scientific Advisor Q2 Solutions/EA Genomics

weida_sq

Dr. Joaquin Dopazo

Vice President

Head of the Clinical Bioinformatics Area
Fundacion Progreso y Salud

steve_sq

Dr. Rebecca Kusko

Deputy Chairperson

SVP, Head of Research and Development
Immuneering Corporation

Shraddha

Dr. Shraddha Thakkar

Executive Secretary

Food and Drug Administration (FDA)

Ini_sq

Dr. Wenjun Bao

Treasurer

Chief Scientist and Sr. Manager
JMP Life Sciences, SAS Institute

Shraddha

Dr. Xiaohui Fan

President-Elect

Professor and Vice Dean
College of Pharmaceutical Sciences
Zhejiang University

Ini_sq

Dr. Leming Shi

Board Member, Past President

Distinguished Professor in School of Life Sciences
Fudan University

Shraddha

Dr. Cesare Furlanello

Board Member, Past President

Head of Data Science and of the MPBA, Fondazione Bruno Kessler (FBK)

Ini_sq

Dr. Chris Mason

Board Member

Associate Professor
Director, WorldQuant (WQ) Init. for Quantitative Prediction & WQ Scholar
Weill Cornell Medicine

Shraddha

Dr. Benjamin Haibe-Kains

Board Member

Scientist, Princess Margaret Cancer Center University Health Network
Assistant Professor, Department of Medical Biophysics University of Toronto

Ini_sq

Dr. Russ Wolfinger

Board Member

Director of Scientific Discovery and Genomics
JMP Genomics, SAS Institute

Shraddha

Dr. Susanna Sansone

Board Member

Associate Professor, Data Readiness
Department of Engineering Science
University of Oxford

Ini_sq

Dr. Matthias Fischer

Board Member

Professor and Senior Physician
Experimental Pediatric Oncology
University Children's Hospital, Cologne, Germany

MAQC Society Board of Directors

A Board of Directors is chartered to develop the Society and oversee the Society’s activities. Specifically, the Board is dedicated to building and strengthening the reproducible science practice by (1) engaging scientists in academia, industry, and government, (2) fostering collaboration and harmonization of education, research tools, and new technologies, and (3) building the global-scientific infrastructure needed to advance and promote reproducible science.
weida_sq

Dr. Weida Tong

Chairperson of the Board - MAQC Society

Director
MCBIOS President
Division of Bioinformatics and Biostatistics National Center for Toxicological Research
Food and Drug Administration (FDA)

steve_sq

Dr. Wendell Jones

President

Principal Bioinformaticist and Scientific Advisor Q2 Solutions/EA Genomics

weida_sq

Dr. Joaquin Dopazo

Vice President

Head of the Clinical Bioinformatics Area
Fundacion Progreso y Salud

steve_sq

Dr. Rebecca Kusko

Deputy Chairperson

SVP, Head of Research and Development
Immuneering Corporation

Shraddha

Dr. Shraddha Thakkar

Executive Secretary

Food and Drug Administration (FDA)

Ini_sq

Dr. Wenjun Bao

Treasurer

Chief Scientist and Sr. Manager
JMP Life Sciences, SAS Institute

Shraddha

Dr. Xiaohui Fan

President-Elect

Professor and Vice Dean
College of Pharmaceutical Sciences
Zhejiang University

Ini_sq

Dr. Leming Shi

Board Member, Past President

Distinguished Professor in School of Life Sciences
Fudan University

Shraddha

Dr. Cesare Furlanello

Board Member, Past President

Head of Data Science and of the MPBA, Fondazione Bruno Kessler (FBK)

Ini_sq

Dr. Chris Mason

Board Member

Associate Professor
Director, WorldQuant (WQ) Init. for Quantitative Prediction & WQ Scholar
Weill Cornell Medicine

Shraddha

Dr. Benjamin Haibe-Kains

Board Member

Scientist, Princess Margaret Cancer Center University Health Network
Assistant Professor, Department of Medical Biophysics University of Toronto

Ini_sq

Dr. Russ Wolfinger

Board Member

Director of Scientific Discovery and Genomics
JMP Genomics, SAS Institute

Shraddha

Dr. Susanna Sansone

Board Member

Associate Professor, Data Readiness
Department of Engineering Science
University of Oxford

Ini_sq

Dr. Matthias Fischer

Board Member

Professor and Senior Physician
Experimental Pediatric Oncology
University Children's Hospital, Cologne, Germany